These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Controversies in the treatment of prostate cancer with maximal androgen deprivation.
    Author: McLeod DG, Moul JW.
    Journal: Surg Oncol Clin N Am; 1995 Apr; 4(2):345-59. PubMed ID: 7796290.
    Abstract:
    The concept of maximal androgen deprivation (MAD) has become the accepted therapy for metastatic prostate cancer. MAD is also under investigation as neoadjuvant therapy prior to radical prostatectomy and radiation therapy. Innovative new approaches, such as intermittent androgen deprivation and new combination therapies, will emerge over the next decade.
    [Abstract] [Full Text] [Related] [New Search]